Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction

Abstract

We investigated the impact of bone marrow-derived mesenchymal stem cells (BM-MSCs) alone or in combination with hepatocyte growth factor (HGF) transplantation via noninfarct-relative artery in a swine myocardial infarction (MI) model. Donor BM-MSCs were derived in vitro from swine auto-bone marrow cultures labeled by bromodeoxyuridine (BrdU) incorporation. Host MI swine model was created by ligating the distal left anterior descending artery. After 4 weeks, age-matched male MI swines were used for the transplantation. Male MI swines were transfused via noninfarct-relative artery with vehicle (control, n=6) or BrdU-labeled BM-MSCs (5 × 106) alone (MSCs, n=6) or BrdU-labeled BM-MSCs (5 × 106) combined with HGF (4 × 109 PFU) (MSCs+HGF, n=6). To evaluate the collateral artery growth (Rentrop) and cardiac perfusion in these animals, gate cardiac perfusion imaging and coronary angiography were performed before and 4 weeks after transplantation, respectively. To assess the contribution of donor-originated cells in stimulation of cardiomyocyte regeneration and angiogenesis, immunohistochemistry for BrdU and α-smooth muscle actin (α-SMA) and quantitative image analysis were performed at 4 weeks after transplantation. The results are as follows: (1) BrdU-positive cells were detected in host myocardium in both MSCs and MSCs+HGF groups, but not in the vehicle group. Most BrdU-positive cells expressed myosin heavy chain β. (2) α-SMA-positive arteriole densities in the infarcted border area and infarcted area were increased significantly in both transplantation groups compared with the vehicle group. (3) Gate cardiac perfusion imaging demonstrated that the cardiac perfusion was significantly improved in transplantation groups compared with the vehicle group. (4) Ejection fraction and α-SMA-positive arteriole densities were increased significantly in both transplantation groups compared with the vehicle group. However, there was no difference in ejection fraction and α-SMA-positive arteriole densities between the MSCs group and the MSCs+HGF group. Growth of collateral arteries was not detected by coronary angiography in all three groups. In conclusion, the current study indicates that BM-MSCs transplantation via noninfarct-relative artery stimulates cardiomyocyte regeneration and angiogenesis and improves cardiac function, but does not stimulate collateral artery growth. BM-MSCs transplantation combined with HGF therapy is not superior to BM-MSCs alone transplantation. BM-MSCs transplantation via noninfarct-relative artery may be an alternative for those patients who cannot be transplanted via infarct-relative artery in clinical practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thoracic Cardiovasc 2002; 123: 1132–1140.

    Article  Google Scholar 

  2. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium. Circulation 2003; 108: 863–868.

    Article  Google Scholar 

  3. Jin H, Wyss JM, Yang R, Schwall R . The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure current. Pharmaceutical Des 2004; 10: 2525–2533.

    CAS  Google Scholar 

  4. Matsumoto K, Nakamura T . Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001; 59: 2023–2038.

    Article  CAS  Google Scholar 

  5. Rentrop KP, Cohen M, Blanke H, Phillips RA . Change in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardial 1985; 5: 587–592.

    Article  CAS  Google Scholar 

  6. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005; 112: 1451–1461.

    Article  Google Scholar 

  7. Orlic D, Hill JM, Arai AE . Stem cells for myocardial regeneration. Circ Res 2002; 91: 1092.

    Article  CAS  Google Scholar 

  8. White FC, Carroll SM, Magnet A, Bloor CM . Coronary collateral development in swine after coronary artery occlusion. Circ Res 1992; 71: 1490–1500.

    Article  CAS  Google Scholar 

  9. Dimmeler S, Zeiher AM, Schneider MD . Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572–583.

    Article  CAS  Google Scholar 

  10. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC . Marrow stromal cells for cellar cardiomyoplasty: feasibility and potential clinical advantages. Thorac cardiovasc surg 2000; 120: 999–1006.

    Article  CAS  Google Scholar 

  11. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infracted myocardium. Nature 2001; 410: 701–705.

    Article  CAS  Google Scholar 

  12. Wakitani S, Saito T, Caplan AI . Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18: 1417–1426.

    Article  CAS  Google Scholar 

  13. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100: II-247–II-256.

    Article  CAS  Google Scholar 

  14. Zhang YR, Wu DL, Lao MF, Bi JJ, Wu ZZ . The comparative efficacy of recombinant adenovirus and plasmid in treatment of myocardial ischemia. Bull Acad Military Med Sci 2003; 27: 16–18.

    CAS  Google Scholar 

  15. Wu DL, Zhang YR, Lao MF, Yuan LZ, Wang L, Ha XQ et al. Therapeutic induction of angiogenesis by direct myocardial administration of an adenovirus vector encoding human hepatocyte growth factor gene and its safety. Chinese Sci Bull 2004; 49: 1464–1469.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the Natural Science Foundation of Jiangsu Province (no. RC2002043).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Z-j Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, Zj., Ma, Dc., Wang, W. et al. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther 13, 1564–1568 (2006). https://doi.org/10.1038/sj.gt.3302820

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302820

Keywords

This article is cited by

Search

Quick links